Vaccine Increases the Diversity and Activation of Intratumoral T Cells in the Context of Combination Immunotherapy.

Horn, Lucas A; Fousek, Kristen; Hamilton, Duane H; Hodge, James W; Zebala, John A; Maeda, Dean Y; Schlom, Jeffrey; Palena, Claudia

Horn, Lucas A; Fousek, Kristen; Hamilton, Duane H; Hodge, James W; Zebala, John A; Maeda, Dean Y; Schlom, Jeffrey; Palena, Claudia.

Afiliação

Horn LA; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Fousek K; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Hamilton DH; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Hodge JW; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Zebala JA; Syntrix Pharmaceuticals, Auburn, WA 98001, USA.
Maeda DY; Syntrix Pharmaceuticals, Auburn, WA 98001, USA.
Schlom J; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Palena C; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Cancers (Basel) ; 13(5)2021 Feb 25.

Article em En | MEDLINE | ID: mdl-33669155

Palavras-chave

TCR diversity; cancer vaccine; combination immunotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google